STAT

Amgen, Merck, and Eli Lilly sue over Trump administration policy to require drug prices in TV ads

Amgen, Merck, Eli Lilly, and the Association of National Advertisers sued the Trump administration over a new policy to require drug prices in TV ads.

WASHINGTON — A trio of pharmaceutical manufacturers on Friday filed suit to overturn one of the most impactful drug pricing policies the Trump administration has enacted to date: a requirement that the companies include a medicine’s list price in direct-to-consumer advertising.

The drug makers — Amgen, Merck, and Eli Lilly — were joined by

You're reading a preview, sign up to read more.

More from STAT

STAT6 min read
Opinion: State Drug Importation Laws Undermine The Process That Keeps Our Supply Chain Safe
State legislators seem dangerously ill-informed about their states' troubled history of counterfeit drugs and are recreating the chaos that preceded the passage of a national track-and-trace system for prescription drugs.
STAT3 min read
Every Data Point Has A Face: What Michael Becker Taught Us
Michael Becker, the patient advocate and former biotech CEO who passed away this week, urged audiences to think beyond the word “data” when talking about studies of patients.
STAT4 min read
Opinion: Opioid Overdose Should Be Treated Like Attempted Suicide: With An Emergency Hold
Having first responders provide a dose of buprenorphine after an overdose rescue is like having them provide Prozac to someone they just pulled from the ledge of a 20-story building…